Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring

Clin Chem Lab Med. 2024 Feb 22;62(8):e181-e184. doi: 10.1515/cclm-2023-1432. Print 2024 Jul 26.

Authors

Pauline Herroelen¹, Hilde Vanpoucke¹, Filip Baert², An-Sofie Decavele¹, Inge De Cuyper¹, Johan Debrabandere¹, Geert A Martens¹, Dieter De Smet¹

Affiliations

¹ AZ Delta Medical Laboratories, 192827 AZ Delta General Hospital , Roeselare, Belgium.
² Department of Gastroenterology and Hepatology, 192827 AZ Delta General Hospital , Roeselare, Belgium.

PMID: 38379379
DOI: 10.1515/cclm-2023-1432

No abstract available

Keywords: CLIA; ELISA; TNF-alpha inhibitor; therapeutic drug monitoring.

Publication types

Letter

MeSH terms

Adalimumab* / blood
Drug Monitoring* / methods
Humans
Immunoassay / methods
Infliximab* / therapeutic use

Substances

Infliximab
Adalimumab